Back to News
investment

Medicare Beneficiaries on These 10 Medications Could Save a Ton in 2026

newsfeedback@fool.com (Kailey Hagen, CFP)
Loading...
3 min read
0 likes
⚡ Quantum Brief
Medicare negotiated 2026 prices for 10 high-cost prescription drugs, reducing out-of-pocket expenses for beneficiaries by 38% to 79% per medication. The steepest discount (79%) applies to Januvia, now priced at $113 for a 30-day supply, while Imbruvica—costing $9,319—received the smallest reduction (38%). A new $2,100 annual cap on Part D out-of-pocket drug costs limits total spending for all beneficiaries this year, easing financial strain on fixed incomes. Negotiated prices include diabetes (Farxiga, Jardiance), blood thinners (Xarelto, Eliquis), and autoimmune treatments (Enbrel, Stelara), covering chronic conditions common among seniors. Future inflation may slightly increase these prices, but 2026 rates remain locked, with beneficiaries advised to confirm coverage details with their Part D providers.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (27).png
Quantum News · Media Library

By Kailey Hagen, CFP – Feb 28, 2026 at 5:30PM ESTKey PointsMedicare has negotiated prices on 10 popular prescription drugs this year.Savings range from 38% to 79% on these drugs.There's an annual out-of-pocket maximum of $2,100 on prescription drug costs in 2026.Even with a Medicare Part D plan, prescription drug costs can take a toll on seniors' finances, especially those living on a fixed income. Fortunately for some, the government has negotiated prices on 10 popular prescription drugs for 2026. Here's a closer look at which drugs are covered and how much you could save on these medications this year. Image source: Getty Images. The 10 negotiated Medicare drugs for 2026 The following table breaks down the 10 drugs the government negotiated prices on, the agreed-upon price for a 30-day supply, and the discount percentage.

Drug Name Price for a 30-Day Supply in 2026 Discount Januvia $113.00 79% Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill $119.00 76% Farxiga $178.50 68% Enbrel $2,355.00 67% Jardiance $197.00 66% Stelara $4,695.00 66% Xarelto $197.00 62% Eliquis $231.00 56% Entresto $295.00 53% Imbruvica $9,319.00 38% Source: Center for Medicare & Medicaid Services. It's also worth noting that there's a $2,100 out-of-pocket maximum for all Part D beneficiaries. So you won't pay more than this for your prescription medications. Keep this in mind as you're mapping out your retirement healthcare budget for the remainder of 2026. If you have any questions about what your plan covers or how much you could pay, contact your Part D plan provider. They should be able to provide you with accurate pricing information. These prices may go up slightly in future years due to inflation. Be sure to keep an eye out for this as you plan for 2027 and beyond.Read NextFeb 28, 2026 •By Maurie BackmanDon't Let RMDs Wreck Your Retirement: 2 Strategies for Minimizing the PainFeb 28, 2026 •By Selena MaranjianSacramento Could Be the "Sweet Spot" Retirement City California Buyers Haven't Noticed YetFeb 28, 2026 •By Kailey Hagen, CFPDo You Have Retirement Savings You Don't Even Know About?Feb 28, 2026 •By James BrumleyThe 401(k) Mistake You Can't Afford to Make in 2026Feb 28, 2026 •By Kailey Hagen, CFPThis "Easy" Retirement Savings Move Could Prove CostlyFeb 28, 2026 •By Maurie BackmanThis Move Could Be the Secret to Saving Your Retirement Portfolio in a Market CrashAbout the AuthorKailey Hagen, CFP, is a contributing Motley Fool retirement analyst covering Social Security, Medicare, and retirement planning.

Before The Motley Fool, Kailey was a research analyst for Reviews.com focusing on credit and banking products. She is a Certified Financial Planner® and holds a bachelor’s degree in English from the University of Wisconsin-Madison.TMFKailey

Read Original

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.